Absci Corporation (ABSI)
(Delayed Data from NSDQ)
$5.06 USD
+0.15 (3.05%)
Updated May 13, 2024 04:00 PM ET
After-Market: $5.07 +0.01 (0.20%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Price, Consensus and EPS Surprise
ABSI 5.06 +0.15(3.05%)
Will ABSI be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for ABSI based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ABSI
Absci (ABSI) to Report Q1 Earnings: Here's What to Expect
Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Tops Revenue Estimates
ABSI: What are Zacks experts saying now?
Zacks Private Portfolio Services
CytomX Therapeutics (CTMX) Surges 214.7%: Is This an Indication of Further Gains?
Absci Corporation (ABSI) Moves 16.8% Higher: Will This Strength Last?
Absci Corporation (ABSI) Surges 10.0%: Is This an Indication of Further Gains?
Other News for ABSI
Largest Clinical-Stage BioTech Drug Stocks Declined 3% Last Week
Absci Q1 2024 Earnings Preview
AI-discovered drugs have an 80%–90% success rate: study
Clinical-Stage BioTech Drug Stocks Portfolio Jumped 7% In First Week Of May
Moderna and OpenAI in pact to fast-track drug development